助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   cirrhosis following hepatitis 的翻译结果: 查询用时:0.194秒
图标索引 在分类学科中查询
所有学科
更多类别查询

图标索引 历史查询
 

cirrhosis following hepatitis
相关语句
  肝炎后肝硬化
     Methods We examined sIL-6R and sgpl30 level in 40 patients with chronic hepatitis(CH), 15 with cirrhosis following hepatitis, and 35 normal controls(NC) in serum by enzyme linked immunosorbent assay (ELISA) method.
     方法应用酶联免疫吸咐法检测慢性肝炎患者40例、肝炎后肝硬化患者15例和35例健康对照者血清中sIL-6R和sgp130水平。
短句来源
     the unusual rate of Serum TBA from patients with chronic hepatitis and cirrhosis following hepatitis was significant difference compared with ALT,AST,ALP and GGY abnormal rate (P < 0.01). Conclusion: The level of serum TBA from the patients with viral hepatitis can reflect damage extent of the live function with higher sensitivity and it has some clinical values in judging damage extent and prognosis of the disease.
     慢性肝炎轻、中、重度及肝炎后肝硬化患者血清TBA异常率与ALT、AST、ALP、GGT异常率比较有显著性差异(P < 0.01)。 结论:病毒性肝炎患者血清TBA水平对反映肝功能受损程度有较高灵敏性,对判断病情活动程度及预后有一定临床价值。
短句来源
     Methods Incidental findings of liver neoplasm were found by pathological examination of cirrhotic liver explant. The primary diseases included cirrhosis following hepatitis B (8 cases), cirrhosis following hepatitis C (1 case), alcoholic cirrhosis (1 case), and primary sclerosing cholangitis (1 case).
     方法11例肝硬化失代偿期患者接受原位肝移植,在术后的病肝病理检查中意外发现癌灶(称之为“意外肝癌”),其原发病,8例为乙型肝炎后肝硬化,丙型肝炎后肝硬化、酒精性肝硬化和原发性硬化性胆管炎各1例。
短句来源
     Effects of human α-interferon on cirrhosis following hepatitis B
     人α—干扰素对乙型肝炎后肝硬化治疗中的作用
短句来源
     Conclusions: Long term treatment with Compound Glycyrrhizin for active cirrhosis following hepatitis B can improve liver function and life quality, prevent exacerbation. And it is not advisable at use interferon for hepatitis B relapsing after Compound Glycyrrhizin withdrawing.
     8例患者未加任何抗病毒药物,经加强保肝、调节免疫等治疗后肝功能得到改善。 结论:乙型肝炎后肝硬化患者伴有活动性病毒复制及肝炎时,长程复方甘草酸苷治疗可改善肝功能,阻止病情进展,提高生活质量,停药后肝炎活动不宜应用干扰素治疗。
短句来源
更多       
  “cirrhosis following hepatitis”译为未确定词的双语例句
     Detection of HBV DNA in the liver tissues of the patients with hepatitic cirrhosis following hepatitis B with gene chips.
     DNA芯片对乙型肝炎肝硬化患者肝组织中病毒的检测
短句来源
     Clinical study of osteoporosis in patients with liver cirrhosis following hepatitis B virus infection
     乙型肝炎肝硬化患者骨质疏松的临床研究
短句来源
     Plasma levels of plasminogen activator system in patients with liver cirrhosis following hepatitis B
     肝硬化患者血浆纤溶酶原活化系统变化及其意义(英文)
短句来源
     Methods A total of 22 patients with hypersplenism of cirrhosis following hepatitis were studied before and after partial splenic artery embolization (PSAE), and 12 cirrhosis with portal hypertension were analysed pre- and post- transjugular intrahepatic portosystemic stent shunt (TIPSS) plus gastric coronary vein emblization (GCVE).
     方法 分析 2 2例部分脾动脉栓塞术和 12例行经颈内静脉肝内门体分流术并胃冠状静脉栓塞术患者的彩色多普勒检查资料。
短句来源
  相似匹配句对
     Effects of human α-interferon on cirrhosis following hepatitis B
     人α—干扰素对乙型肝炎后肝硬化治疗中的作用
短句来源
     Bacterial infection in hepatitis B cirrhosis
     乙型肝炎肝硬化的细菌感染
短句来源
     Plasma levels of plasminogen activator system in patients with liver cirrhosis following hepatitis B
     肝硬化患者血浆纤溶酶原活化系统变化及其意义(英文)
短句来源
     Clinical study of osteoporosis in patients with liver cirrhosis following hepatitis B virus infection
     乙型肝炎肝硬化患者骨质疏松的临床研究
短句来源
     Clinical Analysis on Post-hepatitis Cirrhosis
     肝炎后肝硬化115例临床分析
短句来源
查询“cirrhosis following hepatitis”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
没有找到相关例句


Objective To observe the variation of soluble interleukin-6 receptor(sIL-6R) and soluble interleukin- 6 receptor β strands(sgpl30) in patients with chronic hepatopath. Methods We examined sIL-6R and sgpl30 level in 40 patients with chronic hepatitis(CH), 15 with cirrhosis following hepatitis, and 35 normal controls(NC) in serum by enzyme linked immunosorbent assay (ELISA) method. Results The content of sIL-6R and sgpl30 in serum was higher in CH group(224.27 ug/L and 489.35 ug/L, respectively) than NC...

Objective To observe the variation of soluble interleukin-6 receptor(sIL-6R) and soluble interleukin- 6 receptor β strands(sgpl30) in patients with chronic hepatopath. Methods We examined sIL-6R and sgpl30 level in 40 patients with chronic hepatitis(CH), 15 with cirrhosis following hepatitis, and 35 normal controls(NC) in serum by enzyme linked immunosorbent assay (ELISA) method. Results The content of sIL-6R and sgpl30 in serum was higher in CH group(224.27 ug/L and 489.35 ug/L, respectively) than NC group(174.81 ug/L and 273.64 ug/L respectively). The two parameters above in patients with hepatocirrhosis were higher than those in patients with chronic hepatitis, and the content in order of quantity was severe > moderate > slight. There was significant difference among the three groups(P < 0.05, P < 0.01), and positive correlation between sIL-6R and sgp 130 level(r = 0.481, P < 0.05), between sIL-6R, sgpl30 level and total bilirubin level(r = 0.417, r = 0.428, P < 0.01). While sIL-6R, sgpl30 was no significant correlation to ALT(r = 0.173, r = 0.182, P > 0.05). Conclusion sIL-6R and sgp130 in serum are associated with the development of chronic hepatopath, and therefore can guide the assessment of prognosis.

目的观察慢性肝病患者血清可溶性白介素-6受体(Soluble interleukin-6 receptor,siL-6R)和可溶性IL-6受体β链(sgp130)的变化。方法应用酶联免疫吸咐法检测慢性肝炎患者40例、肝炎后肝硬化患者15例和35例健康对照者血清中sIL-6R和sgp130水平。结果慢性肝炎患者血清sIL-6R和sgp130含量(μg/L)分别为224.27和489.35均显著高于健康对照组(ug/L)分别为174.81和273.64,其中肝炎后肝硬化组患者上述二参数高于慢性肝炎各组;慢性肝炎组中的上述二参数显示为重度>中度>轻度,各组间差异有显著意义;慢性肝病组血清sIL-6R和sgp130水平之间呈正相关(r= 0.481, P< 005), sIL-6R、 sgp130水平与血清总胆红素水平间亦呈正相关(r分别为0.417和0428, P值均< 0.01),与ALT之间无明显相关性(r分别为0.173和0182, P值均>0.05)。结论血清sIL-6R和sgp 130与慢性肝病的病情演变有关,对其预后有一定指导意义。

To observe the effects of "Blood-Activating and Liver-Softening Decoction" on cirrhosis following hepatitis and the markers of fibrosis,100 cases were randomized into treatment group with 50 cases treated by "Blood-Activating and Liver-Softening Decoction" and control group with 50 cases treated by "Ginseng and Trionycis Pill".Six months later,the effects in the two groups were compared.Results showed,in treatment group,that clinical symptoms and signs improved more significantly than those in control...

To observe the effects of "Blood-Activating and Liver-Softening Decoction" on cirrhosis following hepatitis and the markers of fibrosis,100 cases were randomized into treatment group with 50 cases treated by "Blood-Activating and Liver-Softening Decoction" and control group with 50 cases treated by "Ginseng and Trionycis Pill".Six months later,the effects in the two groups were compared.Results showed,in treatment group,that clinical symptoms and signs improved more significantly than those in control group( P <0.05);and that the serum HA,LN and PⅢP reduced more than those in control group( P <0.01).

为观察中药活血软肝汤治疗肝炎后肝硬化的临床疗效及其对纤维化标志物的影响 ,随机分为治疗组和对照组各 5 0例 ,分别采用活血软肝汤和人参鳖甲煎丸进行治疗 ,疗程 6个月。结果 :治疗组的症状体征明显改善 ,肝功能恢复等较对照组好 (P <0 .0 5 ) ,血清HA、LN、PⅢP水平降低 ,较对照组明显 (P <0 .0 1)。提示活血软肝汤对肝炎后肝硬化有较好疗效 ,并能明显降低血清肝纤维化标志物水平。

Objective: To investigate total bile acid (TBA) level in the serums of several types of viral hepatitis and to know its clinical significance. Method: The serums were got from 210 cases of the patients with viral hepatitis. TBA level and the ordinary enzyme index of the liver function were comparatively analyzed. Results: Serum TBA level of the patients with several types of viral hepatitis showed significant different compared with control group (P < 0.01); the unusual rate of Serum TBA from patients with chronic...

Objective: To investigate total bile acid (TBA) level in the serums of several types of viral hepatitis and to know its clinical significance. Method: The serums were got from 210 cases of the patients with viral hepatitis. TBA level and the ordinary enzyme index of the liver function were comparatively analyzed. Results: Serum TBA level of the patients with several types of viral hepatitis showed significant different compared with control group (P < 0.01); the unusual rate of Serum TBA from patients with chronic hepatitis and cirrhosis following hepatitis was significant difference compared with ALT,AST,ALP and GGY abnormal rate (P < 0.01). Conclusion: The level of serum TBA from the patients with viral hepatitis can reflect damage extent of the live function with higher sensitivity and it has some clinical values in judging damage extent and prognosis of the disease.

目的:探讨各型病毒性肝炎血清总胆汁酸(TBA)水平及其临床意义。方法:检测210例病毒性肝炎患者空腹血清TBA水平并与常规肝功能酶学指标ALT、AST、ALP、GGT作对比分析。结果:各型病毒性肝炎患者血清TBA与对照组比较均有显著性差异(P < 0.01);慢性肝炎轻、中、重度及肝炎后肝硬化患者血清TBA异常率与ALT、AST、ALP、GGT异常率比较有显著性差异(P < 0.01)。结论:病毒性肝炎患者血清TBA水平对反映肝功能受损程度有较高灵敏性,对判断病情活动程度及预后有一定临床价值。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关cirrhosis following hepatitis的内容
在知识搜索中查有关cirrhosis following hepatitis的内容
在数字搜索中查有关cirrhosis following hepatitis的内容
在概念知识元中查有关cirrhosis following hepatitis的内容
在学术趋势中查有关cirrhosis following hepatitis的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社